No bellwether trial dates have been set at this stage
When a licensed 503A compounding pharmacy prepares semaglutide, they assign an expiration date based on stability data, ingredient quality, and container integrity
Zepbound (tirzepatide) available in US pharmacies for adults living with obesity owenhaskins Dec 6, 2023 2 min read Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with a BMI of 30kg/m2 or greater) or those who are overweight (with a BMI of 27kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidaemia, type 2 diabetes mellitus, obstructive sleep apnoea or cardiovascular disease, to lose weight and keep it off
Developed by Boehringer Ingelheim/Zealand Pharma
For diarrhoea, maintain hydration and consider simeticone or loperamide after pharmacist advice, or request a dose adjustment if symptoms persist